{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35462789", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "13"}], "Language": ["eng"], "ELocationID": ["8447675", "10.1155/2022/8447675"], "Journal": {"ISSN": "1466-1861", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Mediators of inflammation", "ISOAbbreviation": "Mediators Inflamm"}, "ArticleTitle": "Vitronectin, a Novel Urinary Proteomic Biomarker, Promotes Cell Pyroptosis in Juvenile Systemic Lupus Erythematosus.", "Pagination": {"StartPage": "8447675", "MedlinePgn": "8447675"}, "Abstract": {"AbstractText": ["Identifying new markers of juvenile systemic lupus erythematosus (JSLE) is critical event to predict patient stratification and prognosis. The aim of the present study is to analyze alteration of urinary protein expression and screen potential valuable biomarkers in juvenile systemic lupus erythematosus (JSLE).", "The urine was collected from the patients with or without JSLE and detected by mass spectrometry to analyze proteomic changes. ELISA was used to verify the Vitronectin (VTN) changes in a new set of patients. The clinical correlation was performed to analyze between VTN and clinical pathological parameters. WB and ELISA were used to analyze VTN-mediated cell pyroptosis.", "Herein, we have identified a group of 105 differentially expressed proteins with \u22651.3-fold upregulation or \u22640.77-fold downregulation in JSLE patients. These proteins were involved in several important biological processes, including acute phase inflammatory responses, complement activation, hemostasis, and immune system regulation through Gene Ontology and functional enrichment analysis. Interestingly, urinary ephrin type-A receptor 4 (EPHA4) and VTN were significantly reduced in both inactive and active JSLE patients, and VTN treatment in THP-1 derived macrophages led to a significant increased cell pyroptosis by activation of Nod-like receptor family protein 3 (NLRP3) inflammasomes, resulting in caspase-1 activation, cleaved gasdermin D (GSDMD), and IL-18 secretion. Most importantly, the urinary VTN was also linearly correlated with clinical characteristics of JSLE, implying that VTN could be a specific diagnostic biomarker to distinguish inactive and active JSLE.", "This study provided a novel role of VTN in pyroptosis in JSLE through the urinary proteomic profile for JSLE, which could be a nonintrusive monitoring strategy in clinical diagnosis."], "CopyrightInformation": "Copyright \u00a9 2022 Song Zhang et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Zhang", "ForeName": "Song", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Department of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China."}], "LastName": "Pan", "ForeName": "Wenxu", "Initials": "W"}, {"Identifier": ["0000-0002-7264-6607"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China."}], "LastName": "Wang", "ForeName": "Hongli", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China."}], "LastName": "Zhi", "ForeName": "Cheng", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Heyuan Heping County Maternal and Child Health Hospital, Heyuan, Guangdong 517200, China."}], "LastName": "Lin", "ForeName": "Yanhao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Wu", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Ren", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Wei", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Bionavi Life Sciences Co., Ltd., Shenzhen, Guangdong 518118, China."}], "LastName": "Chen", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Li", "ForeName": "Feng", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Xie", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong 999077, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Wong", "ForeName": "Chun Kwok", "Initials": "CK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute Pasteur of Shanghai, Chinese Academy of Science, Shanghai 200031, China."}], "LastName": "Tang", "ForeName": "Hong", "Initials": "H"}, {"Identifier": ["0000-0001-9853-7380"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China."}], "LastName": "Cai", "ForeName": "Zhe", "Initials": "Z"}, {"Identifier": ["0000-0002-1467-9830"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China."}, {"Identifier": [], "Affiliation": "Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China."}], "LastName": "Xu", "ForeName": "Wanfu", "Initials": "W"}, {"Identifier": ["0000-0002-7166-0941"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China."}], "LastName": "Zeng", "ForeName": "Huasong", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mediators Inflamm", "NlmUniqueID": "9209001", "ISSNLinking": "0962-9351"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "EPHA4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "NLRP3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Vitronectin"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, EphA4"}], "MeshHeadingList": [{"QualifierName": ["urine"], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "physiopathology", "urine"], "DescriptorName": "Lupus Erythematosus, Systemic"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": ["urine"], "DescriptorName": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"QualifierName": [], "DescriptorName": "Proteomics"}, {"QualifierName": ["physiology"], "DescriptorName": "Pyroptosis"}, {"QualifierName": ["urine"], "DescriptorName": "Receptor, EphA4"}, {"QualifierName": ["urine"], "DescriptorName": "Vitronectin"}], "CoiStatement": "The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhang Q., Yin X., Wang H., et al. Fecal metabolomics and potential biomarkers for systemic lupus erythematosus. Frontiers in Immunology . 2019;10:p. 976. doi: 10.3389/fimmu.2019.00976.", "ArticleIdList": ["10.3389/fimmu.2019.00976", "PMC6509220", "31130958"]}, {"Citation": "Barraclough M., McKie S., Parker B., et al. Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes. Annals of the Rheumatic Diseases . 2019;78(7):934\u2013940. doi: 10.1136/annrheumdis-2018-214677.", "ArticleIdList": ["10.1136/annrheumdis-2018-214677", "PMC6585286", "30979715"]}, {"Citation": "Castro-Dopico T., Clatworthy M. R. IgG and Fcgamma receptors in intestinal immunity and inflammation. Frontiers in Immunology . 2019;10:p. 805.", "ArticleIdList": ["PMC6473071", "31031776"]}, {"Citation": "Herrada A. A., Escobedo N., Iruretagoyena M., et al. Innate immune cells' contribution to systemic lupus erythematosus. Frontiers in Immunology . 2019;10:p. 772. doi: 10.3389/fimmu.2019.00772.", "ArticleIdList": ["10.3389/fimmu.2019.00772", "PMC6476281", "31037070"]}, {"Citation": "Sui W., Hou X., Che W., Yang M., Dai Y. The applied basic research of systemic lupus erythematosus based on the biological omics. Genes and Immunity . 2013;14(3):133\u2013146. doi: 10.1038/gene.2013.3.", "ArticleIdList": ["10.1038/gene.2013.3", "23446742"]}, {"Citation": "Arriens C., Wren J. D., Munroe M. E., Mohan C. Systemic lupus erythematosus biomarkers: the challenging quest. Rheumatology (Oxford) . 2017;56(Supplement 1):i32\u2013i45. doi: 10.1093/rheumatology/kew407.", "ArticleIdList": ["10.1093/rheumatology/kew407", "PMC5850341", "28013203"]}, {"Citation": "Lee E. J., Kwon O. C., Ghang B., et al. Immunoglobulin binding protein 1 as a potential urine biomarker in patients with lupus nephritis. International Journal of Molecular Sciences . 2019;20(10):p. 2606. doi: 10.3390/ijms20102606.", "ArticleIdList": ["10.3390/ijms20102606", "PMC6567280", "31137925"]}, {"Citation": "Spinelli F. R., Garufi C., Truglia S., et al. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus. Clinical and Experimental Rheumatology . 2019;37(6):899\u2013905.", "ArticleIdList": ["31074728"]}, {"Citation": "Lee J., Lee J., Baek S., et al. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome. Journal of Autoimmunity . 2019;100:114\u2013119. doi: 10.1016/j.jaut.2019.03.008.", "ArticleIdList": ["10.1016/j.jaut.2019.03.008", "30922727"]}, {"Citation": "Leu C. M., Hsu T. S., Kuo Y. P., et al. Deltex1 suppresses T cell function and is a biomarker for diagnosis and disease activity of systemic lupus erythematosus. Rheumatology (Oxford) . 2019;58(4):p. 740. doi: 10.1093/rheumatology/kez039.", "ArticleIdList": ["10.1093/rheumatology/kez039", "30824925"]}, {"Citation": "Go D. J., Lee J. Y., Kang M. J., et al. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare. Lupus . 2018;27(10):1600\u20131615. doi: 10.1177/0961203318778774.", "ArticleIdList": ["10.1177/0961203318778774", "29958502"]}, {"Citation": "Turnier J. L., Fall N., Thornton S., et al. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Arthritis Research & Therapy . 2017;19(1):p. 242. doi: 10.1186/s13075-017-1444-4.", "ArticleIdList": ["10.1186/s13075-017-1444-4", "PMC5655804", "29065913"]}, {"Citation": "Preissner K. T., Jenne D. Structure of vitronectin and its biological role in haemostasis. Thrombosis and Haemostasis . 1991;66(1):123\u2013132. doi: 10.1055/s-0038-1646380.", "ArticleIdList": ["10.1055/s-0038-1646380", "1718050"]}, {"Citation": "Savill J., Dransfield I., Hogg N., Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature . 1990;343(6254):170\u2013173. doi: 10.1038/343170a0.", "ArticleIdList": ["10.1038/343170a0", "1688647"]}, {"Citation": "Huai Q., Zhou A., Lin L., et al. Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Nature Structural & Molecular Biology . 2008;15(4):422\u2013423. doi: 10.1038/nsmb.1404.", "ArticleIdList": ["10.1038/nsmb.1404", "PMC2443823", "18376415"]}, {"Citation": "Singh B., Janardhan K. S., Kanthan R. Expression of angiostatin, integrin alphavbeta3, and vitronectin in human lungs in sepsis. Experimental Lung Research . 2005;31(8):771\u2013782. doi: 10.1080/01902140500324901.", "ArticleIdList": ["10.1080/01902140500324901", "16368651"]}, {"Citation": "Lopez-Guisa J. M., Rassa A. C., Cai X., Collins S. J., Eddy A. A. Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease. American Journal of Physiology. Renal Physiology . 2011;300(5):F1244\u2013F1254. doi: 10.1152/ajprenal.00701.2010.", "ArticleIdList": ["10.1152/ajprenal.00701.2010", "PMC3094052", "21270094"]}, {"Citation": "Zmijewski J. W., Lorne E., Zhao X., et al. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. American Journal of Respiratory and Critical Care Medicine . 2008;178(2):168\u2013179. doi: 10.1164/rccm.200710-1602OC.", "ArticleIdList": ["10.1164/rccm.200710-1602OC", "PMC2453511", "18436790"]}, {"Citation": "Statland J., Donlin-Smith C. M., Tapscott S. J., Van der Maarel S., Tawil R. Multiplex screen of serum biomarkers in facioscapulohumeral muscular dystrophy. Journal of Neuromuscular Diseases . 2014;1(2):181\u2013190. doi: 10.3233/JND-140034.", "ArticleIdList": ["10.3233/JND-140034", "PMC4332410", "25705588"]}, {"Citation": "Harboe M., Torvund-Jensen J., Kjaer-Sorensen K., Laursen L. S. Ephrin-A1-EphA4 signaling negatively regulates myelination in the central nervous system. Glia . 2018;66(5):934\u2013950. doi: 10.1002/glia.23293.", "ArticleIdList": ["10.1002/glia.23293", "29350423"]}, {"Citation": "De Angelis M. T., Santamaria G., Parrotta E. I., et al. Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus. Journal of Cellular and Molecular Medicine . 2019;23(11):7382\u20137394. doi: 10.1111/jcmm.14598.", "ArticleIdList": ["10.1111/jcmm.14598", "PMC6815917", "31536674"]}, {"Citation": "Gladman D. D., Ibanez D., Urowitz M. B. Systemic Lupus Erythematosus Disease Activity Index 2000. The Journal of Rheumatology . 2002;29(2):288\u2013291.", "ArticleIdList": ["11838846"]}, {"Citation": "Yee C. S., Farewell V., Isenberg D. A., et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis and Rheumatism . 2007;56(12):4113\u20134119. doi: 10.1002/art.23130.", "ArticleIdList": ["10.1002/art.23130", "PMC2659367", "18050213"]}, {"Citation": "Wang Y., Zhou X., Zou K., et al. Monocarboxylate transporter 4 triggered cell pyroptosis to aggravate intestinal inflammation in inflammatory bowel disease. Frontiers in Immunology . 2021;12, article 644862 doi: 10.3389/fimmu.2021.644862.", "ArticleIdList": ["10.3389/fimmu.2021.644862", "PMC8170300", "34093533"]}, {"Citation": "Xu W., Zhang Z., Zou K., et al. MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis. Cell Death & Disease . 2017;8(5, article e2761) doi: 10.1038/cddis.2017.60.", "ArticleIdList": ["10.1038/cddis.2017.60", "PMC5520746", "28471448"]}, {"Citation": "Zhou L., Liu T., Huang B., et al. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. The Journal of Allergy and Clinical Immunology . 2021;147(1):267\u2013279. doi: 10.1016/j.jaci.2020.09.003G.", "ArticleIdList": ["10.1016/j.jaci.2020.09.003G", "32941940"]}, {"Citation": "Poh L., Kang S. W., Baik S. H., et al. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke. Brain, Behavior, and Immunity . 2019;75:34\u201347. doi: 10.1016/j.bbi.2018.09.001.", "ArticleIdList": ["10.1016/j.bbi.2018.09.001", "30195027"]}, {"Citation": "Zhang D., Qian J., Zhang P., et al. Gasdermin D serves as a key executioner of pyroptosis in experimental cerebral ischemia and reperfusion model both in vivo and in vitro. Journal of Neuroscience Research . 2019;97(6):645\u2013660. doi: 10.1002/jnr.24385.", "ArticleIdList": ["10.1002/jnr.24385", "30600840"]}, {"Citation": "Xie J., Fan L., Xiong L., et al. Rabeprazole inhibits inflammatory reaction by inhibition of cell pyroptosis in gastric epithelial cells. BMC Pharmacology and Toxicology . 2021;22(1):p. 44. doi: 10.1186/s40360-021-00509-7.", "ArticleIdList": ["10.1186/s40360-021-00509-7", "PMC8283986", "34266494"]}, {"Citation": "Chauhan A. K., Moore T. L. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC) Clinical and Experimental Immunology . 2006;145(3):398\u2013406. doi: 10.1111/j.1365-2249.2006.03135.x.", "ArticleIdList": ["10.1111/j.1365-2249.2006.03135.x", "PMC1809708", "16907906"]}, {"Citation": "Duncan M. B., Yang C., Tanjore H., et al. Type XVIII collagen is essential for survival during acute liver injury in mice. Disease Models & Mechanisms . 2013;6(4):942\u2013951. doi: 10.1242/dmm.011577.", "ArticleIdList": ["10.1242/dmm.011577", "PMC3701214", "23580202"]}, {"Citation": "de Marcondes P. G., Morgado-Diaz J. A. The role of EphA4 signaling in radiation-induced EMT-like phenotype in colorectal cancer cells. Journal of Cellular Biochemistry . 2017;118(3):442\u2013445. doi: 10.1002/jcb.25738.", "ArticleIdList": ["10.1002/jcb.25738", "27632701"]}, {"Citation": "Khodosevich K., Watanabe Y., Monyer H. EphA4 preserves postnatal and adult neural stem cells in an undifferentiated state in vivo. Journal of Cell Science . 2011;124(8):1268\u20131279. doi: 10.1242/jcs.076059.", "ArticleIdList": ["10.1242/jcs.076059", "21444754"]}, {"Citation": "Chung C. P., Ormseth M. J., Connelly M. A., et al. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus. Lupus . 2016;25(3):296\u2013300. doi: 10.1177/0961203315617842.", "ArticleIdList": ["10.1177/0961203315617842", "PMC4767584", "26637290"]}, {"Citation": "Nordin F., Shaharir S. S., Abdul Wahab A., et al. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus. International Journal of Rheumatic Diseases . 2019;22(8):1419\u20131426. doi: 10.1111/1756-185X.13615.", "ArticleIdList": ["10.1111/1756-185X.13615", "31179646"]}, {"Citation": "Idborg H., Zandian A., Ossipova E., et al. Circulating levels of interferon regulatory factor-5 associates with subgroups of systemic lupus erythematosus patients. Frontiers in Immunology . 2019;10:p. 1029. doi: 10.3389/fimmu.2019.01029.", "ArticleIdList": ["10.3389/fimmu.2019.01029", "PMC6533644", "31156624"]}, {"Citation": "Munro K. M., Dixon K. J., Gresle M. M., et al. EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE) PLoS One . 2013;8(2, article e55948) doi: 10.1371/journal.pone.0055948.", "ArticleIdList": ["10.1371/journal.pone.0055948", "PMC3563632", "23390555"]}, {"Citation": "Pazhouhandeh M., Sahraian M. A., Siadat S. D., et al. A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients. Clinical and Experimental Immunology . 2018;192(1):18\u201332. doi: 10.1111/cei.13087.", "ArticleIdList": ["10.1111/cei.13087", "PMC5842404", "29194580"]}, {"Citation": "Cai Z., Wong C. K., Kam N. W., et al. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Lupus . 2015;24(12):1257\u20131266. doi: 10.1177/0961203315585815.", "ArticleIdList": ["10.1177/0961203315585815", "25966926"]}, {"Citation": "Sumova B., Cerezo L. A., Szczukova L., et al. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatology International . 2019;39(3):469\u2013478. doi: 10.1007/s00296-018-4190-2.", "ArticleIdList": ["10.1007/s00296-018-4190-2", "30392117"]}, {"Citation": "Ajmani S., Singh H., Chaturvedi S., et al. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis. Clinical Rheumatology . 2019;38(4):997\u20131005. doi: 10.1007/s10067-018-4334-5.", "ArticleIdList": ["10.1007/s10067-018-4334-5", "30446886"]}, {"Citation": "Keasey M. P., Jia C., Pimentel L. F., Sante R. R., Lovins C., Hagg T. Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling. Journal of Cell Science . 2017;131(3)", "ArticleIdList": ["PMC5826040", "29222114"]}, {"Citation": "Jia C., Keasey M. P., Malone H. M., et al. Vitronectin from brain pericytes promotes adult forebrain neurogenesis by stimulating CNTF. Experimental Neurology . 2019;312:20\u201332. doi: 10.1016/j.expneurol.2018.11.002.", "ArticleIdList": ["10.1016/j.expneurol.2018.11.002", "PMC6326873", "30408465"]}, {"Citation": "Tochimaru H., Yasuda K., Takekoshi Y., Mastumoto S. Current topics in childhood lupus nephritis. Acta Paediatrica Japonica . 1993;35(5):480\u2013487. doi: 10.1111/j.1442-200X.1993.tb03093.x.", "ArticleIdList": ["10.1111/j.1442-200X.1993.tb03093.x", "8256634"]}, {"Citation": "Yi Y. S. Role of inflammasomes in inflammatory autoimmune rheumatic diseases. The Korean Journal of Physiology & Pharmacology . 2018;22(1):1\u201315. doi: 10.4196/kjpp.2018.22.1.1.", "ArticleIdList": ["10.4196/kjpp.2018.22.1.1", "PMC5746506", "29302207"]}, {"Citation": "Zhang S., Zhe C. A. I., Zhi C., et al.  Proteomic analysis for identification of novel urinary biomarkers in juvenile systemic lupus erythematosus.  2020,  https://www.researchsquare.com/article/rs-103494/v1."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "28"}, {"Year": "2022", "Month": "2", "Day": "9"}, {"Year": "2022", "Month": "3", "Day": "21"}, {"Year": "2022", "Month": "4", "Day": "25", "Hour": "5", "Minute": "11"}, {"Year": "2022", "Month": "4", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["35462789", "PMC9020974", "10.1155/2022/8447675"]}}], "PubmedBookArticle": []}